227 related articles for article (PubMed ID: 37258788)
1. Illustrative Potency Assay Examples from Approved Therapies.
Torrents S; Grau-Vorster M; Vives J
Adv Exp Med Biol; 2023; 1420():139-149. PubMed ID: 37258788
[TBL] [Abstract][Full Text] [Related]
2. [CAR T cells as drugs for novel therapies (advanced therapy medicinal products)].
Köhl U; Abken H
Internist (Berl); 2021 Apr; 62(4):449-457. PubMed ID: 33590292
[TBL] [Abstract][Full Text] [Related]
3. The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma.
Ali S; Kjeken R; Niederlaender C; Markey G; Saunders TS; Opsata M; Moltu K; Bremnes B; Grønevik E; Muusse M; Håkonsen GD; Skibeli V; Kalland ME; Wang I; Buajordet I; Urbaniak A; Johnston J; Rantell K; Kerwash E; Schuessler-Lenz M; Salmonson T; Bergh J; Gisselbrecht C; Tzogani K; Papadouli I; Pignatti F
Oncologist; 2020 Feb; 25(2):e321-e327. PubMed ID: 32043764
[TBL] [Abstract][Full Text] [Related]
4. Potency Assays: The 'Bugaboo' of Stem Cell Therapy.
Torrents S; Grau-Vorster M; Vives J
Adv Exp Med Biol; 2023; 1420():29-38. PubMed ID: 37258782
[TBL] [Abstract][Full Text] [Related]
5. Potency testing of cell and gene therapy products.
Salmikangas P; Carlsson B; Klumb C; Reimer T; Thirstrup S
Front Med (Lausanne); 2023; 10():1190016. PubMed ID: 37215709
[TBL] [Abstract][Full Text] [Related]
6. Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Methods for ATMP Release.
Radrizzani M; Soncin S; Lo Cicero V; Andriolo G; Bolis S; Turchetto L
Methods Mol Biol; 2016; 1416():313-37. PubMed ID: 27236681
[TBL] [Abstract][Full Text] [Related]
7. Release Assays and Potency Assays for CAR T-Cell Interventions.
Dias J; Cadiñanos-Garai A; Roddie C
Adv Exp Med Biol; 2023; 1420():117-137. PubMed ID: 37258787
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)-An Indian Perspective.
Muthu S; Jeyaraman M; Kotner MB; Jeyaraman N; Rajendran RL; Sharma S; Khanna M; Rajendran SNS; Oh JM; Gangadaran P; Ahn BC
Bioengineering (Basel); 2022 Mar; 9(3):. PubMed ID: 35324800
[TBL] [Abstract][Full Text] [Related]
9. Potency assays and biomarkers for cell-based advanced therapy medicinal products.
Capelli C; Cuofano C; Pavoni C; Frigerio S; Lisini D; Nava S; Quaroni M; Colombo V; Galli F; Bezukladova S; Panina-Bordignon P; Gaipa G; Comoli P; Cossu G; Martino G; Biondi A; Introna M; Golay J
Front Immunol; 2023; 14():1186224. PubMed ID: 37359560
[TBL] [Abstract][Full Text] [Related]
10. The Evolving Landscape of Potency Assays.
Burns JS
Adv Exp Med Biol; 2023; 1420():165-189. PubMed ID: 37258790
[TBL] [Abstract][Full Text] [Related]
11. Potency Assay Development: A Keystone for Clinical Use.
Torggler R; Margreiter E; Marksteiner R; Thurner M
Adv Exp Med Biol; 2023; 1420():13-28. PubMed ID: 37258781
[TBL] [Abstract][Full Text] [Related]
12. Bringing function to the forefront of cell therapy: how do we demonstrate potency?
Lowdell MW; Weil B
Front Immunol; 2023; 14():1226841. PubMed ID: 37497223
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Steroid-Refractory Acute Graft-
Murata M; Teshima T
Front Immunol; 2021; 12():724380. PubMed ID: 34489977
[TBL] [Abstract][Full Text] [Related]
14. A new standardized immunofluorescence method for potency quantification (SMPQ) of human conjunctival cell cultures.
Bertolin M; Breda C; Ferrari S; Lamon M; Ponzin D; Ferrari B; Barbaro V
Cell Tissue Bank; 2021 Mar; 22(1):145-159. PubMed ID: 33051810
[TBL] [Abstract][Full Text] [Related]
15. Recent Progress in European Advanced Therapy Medicinal Products and Beyond.
Yu TTL; Gupta P; Ronfard V; Vertès AA; Bayon Y
Front Bioeng Biotechnol; 2018; 6():130. PubMed ID: 30298129
[TBL] [Abstract][Full Text] [Related]
16. Prospects of Advanced Therapy Medicinal Products-Based Therapies in Regenerative Dentistry: Current Status, Comparison with Global Trends in Medicine, and Future Perspectives.
Bakopoulou A
J Endod; 2020 Sep; 46(9S):S175-S188. PubMed ID: 32950189
[TBL] [Abstract][Full Text] [Related]
17. The Art of Stem Cell-Based Therapy.
Burns JS
Adv Exp Med Biol; 2023; 1420():1-12. PubMed ID: 37258780
[TBL] [Abstract][Full Text] [Related]
18. [Cell-based therapies - an innovative therapeutic option in ophthalmology: Treating corneal diseases with stem cells].
Bakker AC; Langer B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1259-64. PubMed ID: 26459569
[TBL] [Abstract][Full Text] [Related]
19. Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in Europe.
Farkas AM; Mariz S; Stoyanova-Beninska V; Celis P; Vamvakas S; Larsson K; Sepodes B
Front Med (Lausanne); 2017; 4():53. PubMed ID: 28560211
[TBL] [Abstract][Full Text] [Related]
20. European regulatory tools for advanced therapy medicinal products.
Flory E; Reinhardt J
Transfus Med Hemother; 2013 Dec; 40(6):409-12. PubMed ID: 24474890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
